Clinical predictors of pathologically response after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma: long term outcomes of a phase II study

about

Clinical predictors of pathologically response after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma: long term outcomes of a phase II study

Item

http://www.wikidata.org/entity/Q58770960

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Clinical predictors of patholo ...... m outcomes of a phase II study

@en

Clinical predictors of patholo ...... m outcomes of a phase II study

@nl

type

Item

label

Clinical predictors of patholo ...... m outcomes of a phase II study

@en

Clinical predictors of patholo ...... m outcomes of a phase II study

@nl

prefLabel

Clinical predictors of patholo ...... m outcomes of a phase II study

@en

Clinical predictors of patholo ...... m outcomes of a phase II study

@nl

P1476

Clinical predictors of patholo ...... m outcomes of a phase II study

@en

P2093

Hong Yang

http://www.w3.org/2001/XMLSchema#string

Jianhua Fu

http://www.w3.org/2001/XMLSchema#string

Jing Wen

http://www.w3.org/2001/XMLSchema#string

Jingping Yun

http://www.w3.org/2001/XMLSchema#string

Kongjia Luo

http://www.w3.org/2001/XMLSchema#string

Lanjun Zhang

http://www.w3.org/2001/XMLSchema#string

Mengzhong Liu

http://www.w3.org/2001/XMLSchema#string

Qianwen Liu

http://www.w3.org/2001/XMLSchema#string

Yihuai Hu

http://www.w3.org/2001/XMLSchema#string

Zihui Tan

http://www.w3.org/2001/XMLSchema#string

P2860

Does the timing of esophagectomy after chemoradiation affect outcome?

Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival.

Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer.

Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer?

Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer.

Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer.

Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer.

The influence of preoperative weight loss on the postoperative course after esophageal cancer resection.

Genetic modulation of ADH1B and ALDH2 polymorphisms with regard to alcohol and tobacco consumption for younger aged esophageal squamous cell carcinoma diagnosis.

Characterization of residual tumours at the primary site in patients with a near pathological complete response after neoadjuvant chemoradiotherapy for oesophageal cancer.

P304

5254-5259

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/JTD.2018.08.88

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30416772

http://www.w3.org/2001/XMLSchema#string

P932

6196203

http://www.w3.org/2001/XMLSchema#string